UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030087
Receipt number R000034350
Scientific Title Examination on the action of botanical extracts on brain functions
Date of disclosure of the study information 2017/11/22
Last modified on 2018/04/18 13:17:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination on the action of botanical extracts on brain functions

Acronym

Examination on the action of botanical extracts on brain functions

Scientific Title

Examination on the action of botanical extracts on brain functions

Scientific Title:Acronym

Examination on the action of botanical extracts on brain functions

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine an influence of a test food product on brain functions by selecting healthy males and females of Japanese nationality aged 50 and over, below 70 as subjects and assigning them to take the test food product for 12 weeks on a continuous basis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement effects of Cognitrax on brain functions

Key secondary outcomes

Blood concentration of BDNF, blood concentration of inflammatory cytokines(TNF-,IL-6,IL-1),
BAP levels and d-ROMs in blood, urinary 8-0HdG, and isoprostane in urine


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

4-week intake of the test food

Interventions/Control_2

4-week intake of the placebo food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Age: 50 and over, below 70
2)Sex: Males and females with Japanese nationality
3)Persons who are aware of a decline in cognitive functions

Key exclusion criteria

1)Currently in treatment with medication or currently seeing a doctor for treatment
2)Previous history of hepatic disorder, severe kidney, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological, or metabolic disorder, or a complication of these.
3)Previous history of drug allergy or food allergy
4)Current intake of a health food product or supplements with a possible influence on the cognitive functions
5)Current administration of medication with a possible influence on the cognitive functions
6)Extreme faddiness
7)Extremely irregular lifestyle habits such as eating and sleeping habits
8)Suspected insomnia
9)Presence or previous history of mental disorder (depression, etc.)
10)Presence or previous history of alcoholism
11)Current participation in any other clinical study or participation in other clinical study in the past three months
12)Night shifts or irregular work schedule
13)Determined by the investigator to be unsuitable for enrollment in this study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ochitani Daisuke

Organization

HUMA R&D CORP

Division name

Clinical Development Division

Zip code


Address

Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan

TEL

81-3-3431-1260

Email

ochitani@huma-c.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ochitani Daisuke

Organization

HUMA R&D CORP

Division name

Clinical Development Division

Zip code


Address

Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan

TEL

81-3-3431-1260

Homepage URL


Email

ochitani@huma-c.co.jp


Sponsor or person

Institute

HUMA R&D CORP

Institute

Department

Personal name



Funding Source

Organization

Ezaki Glico Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 13 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 20 Day

Last follow-up date

2018 Year 02 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 22 Day

Last modified on

2018 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034350


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name